Vynleads

GLP-1 & Diabetes

GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) — have changed the conversation around type 2 diabetes and weight. This hub answers the questions people actually search: how long the medicines take to work, what the first weeks feel like, why hunger sometimes comes back, how to handle side effects like constipation or nausea, and how much protein and strength training it takes to keep muscle while losing weight. Every guide is educational — never start, stop, or change a dose based on an article. Prescribing decisions belong with your care team, and lifestyle habits support these medicines; they are not a replacement for them.

All GLP-1 & Diabetes Articles

Related Topic Hubs